Skip to content
  • Sunday, 26 July 2026
  • 3:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and Uganda
Laboratory Automation & Robotics

CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and Uganda

Lana Keisha Jul 12, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…

Read More
Laboratory Automation & Robotics

CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo Outbreak

Lana Keisha Jun 5, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…

Read More
Environmental & Analytical Chemistry

Unraveling the Mysteries of the Bundibugyo Virus: A Race Against a Rare and Deadly Outbreak in the Democratic Republic of Congo

Abdurrohim Arsyad Jun 4, 2026 0

As an Ebola outbreak grows in the Democratic Republic of the Congo, researchers are scrambling to learn more about the…

Read More
Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug AccessScientific Breakthrough Confirms Pianists Shape Timbre Through Touch Precision and Motor ControlRegional Bone Marrow Niches in the Skull Identified as Potent Reservoirs for Glioblastoma DefenseTWiV 1284: Clinical Update with Dr. Daniel Griffin
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ